Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.

about

Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.

Item

http://www.wikidata.org/entity/Q47707224

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@en

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@nl

type

Item

label

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@en

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@nl

prefLabel

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@en

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@nl

P1476

Contemporary use of P2Y12 inhi ...... from ORPKI national registry.

@en

P2093

Artur Dziewierz

http://www.w3.org/2001/XMLSchema#string

Krzysztof Plens

http://www.w3.org/2001/XMLSchema#string

Paweł Kleczyński

http://www.w3.org/2001/XMLSchema#string

Tomasz Rakowski

http://www.w3.org/2001/XMLSchema#string

Zbigniew Siudak

http://www.w3.org/2001/XMLSchema#string

P2860

Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry

Percutaneous interventions in cardiology in Poland in the year 2014. Summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society AISN PTK.

Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry

Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines.

Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).

Switching P2Y12-receptor inhibitors in patients with coronary artery disease.

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience.

Assessment of P2Y12 inhibitor usage and switching in acute coronary syndrome patients undergoing percutaneous coronary revascularization.

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.

P2888

s11239-017-1579-9

P304

151-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-017-1579-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dariusz Dudek

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29075924

http://www.w3.org/2001/XMLSchema#string

P932

5756271

http://www.w3.org/2001/XMLSchema#string